All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Cognitive

Cognitive Decline

By FormBlends Medical Team · Last reviewed April 2026

Cognitive decline refers to a measurable reduction in memory, focus, processing speed, or executive function beyond what is expected for a person's age. Mild cognitive impairment affects 12 to 18% of adults over 60. Neuroprotective peptides and NAD+ precursors are being studied for their ability to support neuronal health and cognitive function.

Mild cognitive impairment affects 12 to 18% of adults over 60

FormBlends Condition Context

Reviewed May 14, 2026

Cognitive Decline condition guide matters because the search behind it is usually practical. The reader is trying to understand condition-specific care, but the safer answer depends on context: diagnosis, medications, labs, dosing, access, price, and follow-up. This page should help narrow the next question before a licensed clinician or qualified provider weighs in.

  • Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
  • Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
  • Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.

Common Symptoms

  • Difficulty remembering recent events or conversations
  • Trouble concentrating on tasks for sustained periods
  • Slower mental processing and reaction times
  • Difficulty finding the right words during conversation
  • Reduced ability to multitask or plan ahead
  • Increased reliance on notes and reminders

Common Causes

  • Age-related neuronal loss and reduced synaptic density
  • Chronic neuroinflammation
  • Poor cerebral blood flow from cardiovascular risk factors
  • Sleep deprivation impairing glymphatic clearance
  • Nutrient deficiencies including B12, omega-3s, and vitamin D

Treatment Options

Peptide

Semax

Semax is a synthetic analog of ACTH(4-10) that has been studied for neuroprotective and nootropic effects, including upregulation of BDNF and enhanced cerebral circulation.

Learn more about Semax
Peptide

Selank

Selank is a tuftsin-derived peptide with anxiolytic and nootropic properties. Research suggests it modulates GABA and serotonin systems while supporting cognitive function.

Learn more about Selank
Peptide

NAD+

NAD+ is a coenzyme critical for mitochondrial energy production and DNA repair. Supplementation supports cellular energy in neurons and may slow age-related cognitive decline.

Learn more about NAD+
Lifestyle

Lifestyle Interventions

Regular aerobic exercise, consistent sleep schedules, and cognitive training exercises have strong evidence for maintaining and improving brain function.

Find Treatment for Cognitive Decline

Browse clinics near you that treat cognitive decline.

Find Clinics

Frequently Asked Questions

What is cognitive decline?
Cognitive decline refers to a measurable reduction in memory, focus, processing speed, or executive function beyond what is expected for a person's age. Mild cognitive impairment affects 12 to 18% of adults over 60. Neuroprotective peptides and NAD+ precursors are being studied for their ability to support neuronal health and cognitive function.
What are the symptoms of cognitive decline?
Difficulty remembering recent events or conversations, Trouble concentrating on tasks for sustained periods, Slower mental processing and reaction times, Difficulty finding the right words during conversation, Reduced ability to multitask or plan ahead, Increased reliance on notes and reminders.
What treatments are available for cognitive decline?
Semax, Selank, NAD+, Lifestyle Interventions.